Quantcast

Latest GlaxoSmithKline Stories

2014-09-29 08:31:20

DUBLIN, Sept. 29, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Hepatitis B Vaccines Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Hepatitis B is an inflammatory condition that occurs due to infection by hepatitis B virus. Hepatitis B virus is an enveloped virus that belongs to the family of hepadnavirus. It contains a circular genome with partially double-stranded DNA. The virus interferes with the...

2014-09-29 08:30:22

DUBLIN, Sept. 29, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Infectious Disease Treatment Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Infectious diseases can be caused by various pathogenic microorganisms such as bacteria, fungi, parasites, or viruses. These diseases can be transmitted from one individual to another through either direct contact or indirect contact. Anti-infective drugs are used to...

2014-09-22 08:28:00

Companies Include Silarus Therapeutics Developing Treatments for Anemia and Iron Overload Disorders; and Thyritope Biosciences Developing Treatments for Graves' Orbitopathy SAN DIEGO, Sept. 22, 2014 /PRNewswire/ -- Avalon Ventures today announced the launch of two new companies formed through its collaboration with GlaxoSmithKline (GSK) to fund and launch up to 10 early-stage life science companies. Silarus Therapeutics, Inc. and Thyritope Biosciences, Inc. each will receive up to...

2014-09-21 23:01:40

LifeScienceIndustryResearch.com adds “Flovent (Asthma) – Forecast and Market Analysis to 2023” to its store. Obtain sales forecast for Flovent from 2013-2023 in top eight countries (the US, France, Germany, Italy, Spain, the UK, Japan and Australia). Dallas, Texas (PRWEB) September 21, 2014 Originally approved by the Food and Drug Administration (FDA) in 1996, GSK’s Flovent (fluticasone propionate) is a synthetic ICS therapy with potent anti-inflammatory activity. It is used for...

2014-09-11 08:28:56

Accomplished trio join a Board managing the challenges and opportunities of growth WORCESTER, Mass., Sept. 11, 2014 /PRNewswire-USNewswire/ -- Wake Up Narcolepsy (WUN), a nonprofit organization working to improve the lives of people living with narcolepsy, today announced the appointment of three new members of its Board of Directors, effective immediately. http://photos.prnewswire.com/prnvar/20140910/145218 Raymond De Rise has extensive legal and compliance experience in the...

2014-09-11 04:21:18

OXFORD, England, September 11, 2014 /PRNewswire/ -- Successful Completion of Biomedical Catalyst Programme Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces that it has confirmed the potential of its Multi-component Particle(TM) (MCP(TM)) Technology for creating novel inhaled, dual and triple fixed dose combination (FDC) therapies for respiratory diseases. The Company...

2014-09-08 16:25:06

DALLAS, September 8, 2014 /PRNewswire/ -- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates is a 266 pages, 2014 market research report now available with ReportsnReports.com at http://www.reportsnreports.com/reports/297438-countryfocus-healthcare-regulatory-and-reimbursement-landscape-united-arab-emirates.html . This research says the United Arab Emirates (UAE) is second only to Saudi Arabia in terms of pharmaceutical investment in...

2014-09-05 08:23:21

PITTSBURGH, Sept. 5, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Ibandronate Sodium Injection, 1 mg (base)/mL, packaged in 3 mg (base)/3 mL pre-filled glass syringes, which is the generic version of Hoffmann-La Roche's Boniva® Injection. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment of osteoporosis in...

2014-09-04 16:26:50

PARSIPPANY, N.J., Sept. 4, 2014 /PRNewswire/ -- GlaxoSmithKline (GSK) Consumer Healthcare applauds CVS for its courageous decision to end the sale of tobacco products. This monumental step will go a long way towards improving and protecting public health. Banning the sale of cigarettes and other harmful tobacco products from its shelf will help CVS encourage current smokers to quit, may prevent potential smokers from starting the deadly habit and may ultimately reduce the prevalence...

2014-09-03 16:30:04

EDISON, N.J., Sept. 3, 2014 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc. (OTCBB:CTRV), an emerging biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today it will present at two upcoming investor conferences. ContraVir is scheduled to present at the Rodman & Renshaw 16(th) Annual Global Investment Conference, to be held September 8-10, 2014, in New York City, and the Aegis Capital 2014 Healthcare and Technology...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related